Delivery Order 36F79723D0126-36C25226N0252
- Avedro, Inc., a subsidiary of Glaukos Corporation specializing in ophthalmic medical devices, was awarded a firm fixed-price delivery order valued at $95,897.52 by Veterans Integrated Service Network 12 on June 15, 2024, for IDOSE TR 75 CMG implants. This delivery order, which is not set-aside designated, is issued under the parent Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract, enabling streamlined procurement of specialized medical products. The contract specifies...
- This federal contract award, valued at $21,310.56, was issued by the U.S. Department of Veterans Affairs (VA) to Avedro, Inc., a subsidiary of Glaukos Corporation. The contract is for the supply of PROS IMPLANT medical devices, which are specialized ophthalmic products. The contract is a firm-fixed-price purchase order with no set-aside designation, indicating Avedro competed on a full and open basis. Avedro, Inc. has established itself as a key supplier of advanced medical technologies,...
- This is a federal contract award by the U.S. Department of Veterans Affairs (VA) to Avedro, Inc., a subsidiary of Glaukos Corporation, for the delivery of IDOSE TR 75 MGC IMPLANT medical devices. The $10,655.28 firm-fixed-price contract has an ultimate completion date of August 14, 2025. Avedro, Inc. is a for-profit medical device and pharmaceutical manufacturer specializing in advanced ophthalmic technologies. The contract is not set-aside and is part of Avedro's broader Federal Supply Schedule...
- This federal contract award is for the procurement of IDOSE TR 75MCG IMPLANT TRADE medical devices by the U.S. Department of Veterans Affairs (VA). The prime contractor is Avedro, Inc., a subsidiary of Glaukos Corporation, a for-profit medical device manufacturer specializing in ophthalmic products. The contract is a firm-fixed-price delivery order with a ceiling value of $21,310.56 and an ultimate completion date of January 31, 2026. This award is not associated with a set-aside designation,...
- This federal contract award is for the purchase of IDOSE TRAVOPROST 75MCG IMPLANTS by the U.S. Department of Veterans Affairs (VA) through Veterans Integrated Service Network 23 (VISN 23). The $21,340.56 firm-fixed-price purchase order was awarded to Glaukos Corporation, a for-profit medical device manufacturer, on May 12, 2025, with a completion date of June 11, 2025. The contract has no set-aside designation, indicating Glaukos competed on a full and open basis. Glaukos also holds a Federal...
- This firm-fixed-price purchase order was awarded by the U.S. Department of Veterans Affairs (VA) to Glaukos Corporation, a for-profit medical device manufacturer, for the provision of a prosthetic surgical implant for the right eye. The contract award, valued at $21,340.56, has an ultimate completion date of May 30, 2025. The contract is not set aside and was awarded through the Veterans Integrated Service Network 23 (VISN 23). Glaukos Corporation, through its subsidiary Avedro, Inc., also holds...
- This firm-fixed-price purchase order was awarded by the Department of Veterans Affairs (VA) to Glaukos Corporation, a for-profit medical device manufacturer, for the delivery of specialized ophthalmic products and medical implants. The contract, valued at $21,340.56, has an ultimate completion date of June 11, 2025. This award is not a set-aside contract, indicating Glaukos Corporation competed on a full and open basis. The company has a history of providing advanced medical technologies, such...
- This is a firm-fixed-price purchase order awarded by the U.S. Department of Veterans Affairs (VA) to Glaukos Corporation, a for-profit medical device manufacturer. The $21,340.56 contract is for the supply of prosthetics and surgical implants, specifically for the VA's Veterans Integrated Service Network (VISN) 23. The award has an ultimate completion date of May 13, 2025. Glaukos Corporation, through its subsidiary Avedro, Inc., also holds a Federal Supply Schedule (FSS) contract with the VA...
- This federal contract award was issued by the Defense Health Agency (DHA), a defense agency, to Avedro, Inc., a for-profit manufacturer of medical devices and pharmaceuticals, particularly ophthalmic products. The contract, a $85,900.00 firm-fixed-price purchase order, is for the delivery of a KXL Device, 110-02723. The contract does not have a set-aside designation, indicating it was competed on a full and open basis. Avedro, Inc. is a subsidiary of Glaukos Corporation and has an established...
- This is a firm-fixed-price purchase order awarded by the Veterans Integrated Service Network 16 (VISN 16), a division of the U.S. Department of Veterans Affairs (VA), to Avedro, Inc., a for-profit manufacturer of medical devices and pharmaceuticals. The contract is for the provision of a Corneal Crosslinking Device, with a ceiling value of $89,400.00 and a period of performance ending on July 13, 2017. The contract was set aside for small businesses. Avedro, Inc. holds two Federal Supply...
- Pharmaceuticals and Drugs (FSS-61-IB)Master GSA Schedule
- 36F79723D0126Federal Supply Schedule
- 36F79723D0126-36C25226N0252Delivery Order
Avedro, Inc., a subsidiary of Glaukos Corporation specializing in ophthalmic medical devices and pharmaceuticals, was awarded a delivery order valued at $169,104.64 for Travoprost 75 micrograms by Veterans Integrated Service Network 12 (VISN 12), a civilian agency within the Department of Veterans Affairs. The contract, awarded February 1, 2026, with an ultimate completion date of January 31, 2027, operates under a firm fixed-price structure with no set-aside designation. The place of performance is located in Waltham, Massachusetts. This delivery order is issued against Avedro's broader Federal Supply Schedule contract under the Pharmaceuticals and Drugs (FSS-61-IB) schedule, which carries a ceiling value of $584,000.00 and enables streamlined acquisition of specialized ophthalmic pharmaceutical products across multiple VA regional networks. The award reflects Avedro's established position as a pre-approved supplier within the VA healthcare procurement ecosystem, having consistently demonstrated capability to deliver specialized pharmaceutical implants and solutions to various Veterans Integrated Service Networks on a competitive, full and open basis. Travoprost is a prostaglandin analog ophthalmic medication commonly used in the treatment of glaucoma and ocular hypertension, aligning with Glaukos Corporation's core focus on innovative eye-related medical technologies. The delivery order structure provides VISN 12 with efficient access to this specialized medication through an existing indefinite delivery vehicle, facilitating responsive procurement for VA healthcare facilities serving veterans.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $169.1k | 3/2/26 |